ST waveform analysis vs cardiotocography alone for intrapartum fetal monitoring: An updated systematic review and meta‐analysis of randomized trials
Acta Obstetricia et Gynecologica Scandinavica · 2024
DOI: 10.1111/aogs.14752 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, 2024. Verfasst von Ellen Blix und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway. Hauptthemen laut MEDLINE: Cardiotocography, Randomized Controlled Trials as Topic, Fetal Distress. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
ST waveform analysis (STAN) was introduced as an adjunct to cardiotocography (CTG) to improve neonatal and maternal outcomes. The aim of the present study was to quantify the efficacy of STAN vs CTG and assess the quality of the evidence using GRADE. Material and methods We performed systematic literature searches to identify randomized controlled trials and assessed included studies for risk of bias. We performed meta‐analyses, calculating pooled risk ratio (RR) or Peto odds ratio (OR). We also performed post hoc trial sequential analyses for selected outcomes to assess the risk of false‐positive results and the need for additional studies.
Results
Nine randomized controlled trials including 28 729 women were included in the meta‐analysis. There were no differences between the groups in operative deliveries for fetal distress (10.9 vs 11.1%; RR 0.96; 95% confidence interval [CI] 0.82–1.11). STAN was associated with a significantly lower rate of metabolic acidosis (0.45% vs 0.68%; Peto OR 0.66; 95% CI 0.48–0.90). Accordingly, 441 women need to be monitored with STAN instead of CTG alone to prevent one case of metabolic acidosis. Women allocated to STAN had a reduced risk of fetal blood sampling compared with women allocated to conventional CTG monitoring (12.5% vs 19.6%; RR 0.62; 95% CI 0.49–0.80). The quality of the evidence was high to moderate.
Conclusions
Absolute effects of STAN were minor and the clinical significance of the observed reduction in metabolic acidosis is questioned. There is insufficient evidence to state that STAN as an adjunct to CTG leads to important clinical benefits compared with CTG alone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway.
- The Norwegian Institute of Public Health, Oslo, Norway.
- Center for Evidence Based Practice, Western Norway University of Applied Sciences, Bergen, Norway.
- Science and Health Library, University Library, UiT The Arctic University of Norway, Tromsø, Norway.
- Department of Obstetrics and Gynecology, University Hospital of North Norway, Tromsø, Norway.
ORCID-Profile: Ellen Blix
Zitieren
APA
Blix, E., Brurberg, K. G., Reierth, E., Reinar, L. M., & Øian, P. (2024). ST waveform analysis vs cardiotocography alone for intrapartum fetal monitoring: An updated systematic review and meta‐analysis of randomized trials. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.14752
Vancouver
Blix E, Brurberg KG, Reierth E, Reinar LM, Øian P. ST waveform analysis vs cardiotocography alone for intrapartum fetal monitoring: An updated systematic review and meta‐analysis of randomized trials. Acta Obstetricia et Gynecologica Scandinavica. 2024. doi:10.1111/aogs.14752
BibTeX
@article{Blix2024,
author = {Blix, Ellen and Brurberg, Kjetil Gundro and Reierth, Eirik and Reinar, Liv Merete and Øian, Pål},
title = {ST waveform analysis vs cardiotocography alone for intrapartum fetal monitoring: An updated systematic review and meta‐analysis of randomized trials},
journal = {Acta Obstetricia et Gynecologica Scandinavica},
year = {2024},
doi = {10.1111/aogs.14752}
}
EUVIMED